Stocks

ARS Pharmaceuticals, Inc. $7.8 million in total neffy U.S. net product revenue in first quarter of 2025 neffy1 mg available nationwide for children aged four and older and co-promotion agreement with ALK-Abelló Inc. increases neffy promotional reach to nearly 20,000 healthcare providers, including key …

Diluted EPS of $(0.06), adjusted diluted EPS1 of $0.96 EBITDA of $158.3 million, adjusted EBITDA attributable to shareholders1 of $273.9 million EBITDA per share of $1.09 and adjusted EBITDA attributable to shareholders1 per share of $1.88 Operating cash flow of $148.4 million, free cash …

Boralex Inc. MONTREAL, May 14, 2025 (GLOBE NEWSWIRE) -- Boralex Inc. (“Boralex” or the “Corporation”) (TSX: BLX) is pleased to report its results for the first quarter of 2025. Highlights Financial results Lower EBITDA(A)1, operating income and net earnings in Q1-2025 Production down 4% …

BioCryst Pharmaceuticals, Inc. –FDA grants Priority Review of application, with PDUFA target action date of September 12, 2025– –ORLADEYO would be the first targeted oral prophylactic therapy for patients with HAE under the age of 12, if approved– RESEARCH TRIANGLE PARK, N.C., May 14, …

Cellebrite DI Ltd First-Quarter 2025 revenue of $107.5 million grew 20% primarily due to21% growth in subscription revenue ARR grew 23% to $408.0 million First-Quarter 2025 adjusted EBITDA of $23.7 million, 22.0% adjusted EBITDA margin TYSONS CORNER, Va. and PETAH TIKVA, Israel, May 14, …

Global-e Online Ltd PETAH-TIKVA, Israel, May 14, 2025 (GLOBE NEWSWIRE) -- Global-e Online Ltd. (Nasdaq: GLBE) the platform powering global direct-to-consumer e-commerce, today reported financial results for the first quarter of 2025. “We had another quarter of strong results, demonstrating our ability to grow …

Ligand Pharmaceuticals JUPITER, Fla., May 14, 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that the company will ring The Nasdaq Stock Market Opening Bell on Monday, May 19, 2025. CEO Todd Davis will be joined by members of Ligand’s senior …